Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Glycopyrrolate is typically one of the first treatments for craniofacial hyperhidrosis (excessive sweating of the face and head) and the second or third treatment for palmar, plantar, or axillary hyperhidrosis (excessive sweating of the palms, soles, and armpits)
Dosage: 250-420mg daily
Feeling cold is not documented as an official adverse effect in UK regulatory documentation or clinical trials, though some patients report increased cold sensitivity, particularly those experiencing substantial weight loss
Muscle pain from tirzepatide typically emerges within the first four to eight weeks of therapy and peaks within two to three weeks of onset
The role of menopause hormone therapy in modulating tirzepatide-associated weight loss in postmenopausal women with overweight or obesity: A retrospective cohort study
